440
Participants
Start Date
October 25, 2021
Primary Completion Date
October 25, 2025
Study Completion Date
March 1, 2026
Methylprednisolone
In the experimental group, methylprednisolone will be administered intravenously for 5 days at a dose of 1 mg/kg/day. Methylprednisolone will be provided for reconstitution and dilution in 50 ml of NaCl 0.9% solution and administered over 15 minutes, once a day.
Placebos
in the control group, placebo will be administered intravenously for 5 days. Placebo will be identical (color and aspect) to experimental substance, will be provide as a 50 mL of NaCl 0.9% solution and administered intravenously over 15 minutes, once a day.
RECRUITING
CH d'Annecy Genevois, Metz-Tessy
RECRUITING
André Mignot Hospital, Intensive care unit, Le Chesnay
RECRUITING
CHU de Bicêtre, Le Kremlin-Bicêtre
RECRUITING
CHU Angers, Angers
NOT_YET_RECRUITING
CH métropole savoie, Chambéry
RECRUITING
CHU Louis Mourier, Colombes
NOT_YET_RECRUITING
CHU Henri mondor, Créteil
RECRUITING
CHU Dijon, Dijon
RECRUITING
CHU Grenoble, Grenoble
RECRUITING
CHD Vendée, La Roche-sur-Yon
RECRUITING
CH Le Mans, Le Mans
RECRUITING
CHRU lille, Lille
RECRUITING
CHU Lyon, Lyon
NOT_YET_RECRUITING
CHU Nantes, Nantes
RECRUITING
CHR orléans, Orléans
RECRUITING
CHU Cochin, Paris
RECRUITING
Hôpital européen Georges pompidou, Paris
RECRUITING
Pitié-Salpêtrière, Paris
RECRUITING
CHU Poitiers, Poitiers
RECRUITING
CHU de Rennes, Rennes
NOT_YET_RECRUITING
CHU de Rouen, Rouen
ACTIVE_NOT_RECRUITING
Hopital Foch, Suresnes
RECRUITING
CHRU Tours, Tours
Versailles Hospital
OTHER